Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with and without HIV infection: a cohort study, 1999-2011

Introduction. High activity antiretroviral therapy (HAART) has allowed people infected with human immunodeficiency virus (HIV) to live longer. In the course of time, hepatocellular carcinoma (HCC) began to be found in th...

Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in Western countries, and its prevalence is increasing worldwide. It currently affects approximately 30% of adults and 10% of children an...

Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic liver diseases

Tenofovir as a first line option for prophylaxis in a patient with hepatitis B virus associated nephrotic syndrome

Etiology of hepatocellular carcinoma in Latin America: a prospective, multicenter, international study

Background/aims. No prospective study has been published investigating etiology of HCC in Latin America. The primary aim of this prospective study was to analyze the etiology of liver disease in patients with HCC from ou...